Display options
Share it on

Mol Genet Metab Rep. 2017 Jan 27;10:84-91. doi: 10.1016/j.ymgmr.2017.01.005. eCollection 2017 Mar.

Sex-specific effects of serum sulfate level and .

Molecular genetics and metabolism reports

Christina G Tise, Leslie E Anforth, Albert E Zhou, James A Perry, Patrick F McArdle, Elizabeth A Streeten, Alan R Shuldiner, Laura M Yerges-Armstrong

Affiliations

  1. Program for Personalized and Genomic Medicine and Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, MD, United States.

PMID: 28154797 PMCID: PMC5278115 DOI: 10.1016/j.ymgmr.2017.01.005

Abstract

CONTEXT: Sulfate is critical in the biotransformation of multiple compounds via sulfation. These compounds include neurotransmitters, proteoglycans, xenobiotics, and hormones such as dehydroepiandrosterone (DHEA). Sulfation reactions are thought to be rate-limited by endogenous sulfate concentrations. The gene,

OBJECTIVE: To examine the effect of serum sulfate concentration and sulfate-lowering genotype on DHEA homeostasis.

DESIGN: Retrospective cohort study.

SETTING: Academic research.

PATIENTS: Participants of the Amish Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study and the Amish Hereditary and Phenotype Intervention (HAPI) Study.

MAIN OUTCOME MEASURES: DHEA, DHEA-S, and DHEA-S/DHEA ratio.

RESULTS: Increased serum sulfate was associated with decreased DHEA-S (

CONCLUSIONS: Our results demonstrate an inverse relationship between serum sulfate, and DHEA-S and DHEA-S/DHEA ratio in men, while also suggesting that the sulfate-lowering variants,

Keywords: DHEA; DHEA-S; SLC13A1; Serum sulfate; Sulfation

References

  1. Eur J Clin Invest. 2000 Dec;30 Suppl 3:46-50 - PubMed
  2. J Endocrinol. 1973 Apr;57(1):123-34 - PubMed
  3. Am J Med Genet A. 2013 Jun;161A(6):1300-8 - PubMed
  4. J Clin Endocrinol Metab. 2013 Sep;98(9):3848-55 - PubMed
  5. Hum Mutat. 2013 Oct;34(10 ):1381-6 - PubMed
  6. Endocr Rev. 2005 Apr;26(2):171-202 - PubMed
  7. Mol Psychiatry. 2015 Mar;20(3):369-76 - PubMed
  8. Nat Genet. 1998 Oct;20(2):157-62 - PubMed
  9. Physiology (Bethesda). 2007 Jun;22:212-25 - PubMed
  10. N Engl J Med. 2009 May 28;360(22):2310-8 - PubMed
  11. JAMA. 2009 Aug 26;302(8):849-57 - PubMed
  12. Endocr Rev. 2002 Oct;23(5):703-32 - PubMed
  13. Biochem J. 1962 Jul;84:106-10 - PubMed
  14. Neuro Endocrinol Lett. 2007 Oct;28(5):565-73 - PubMed
  15. Biochem Genet. 2013 Feb;51(1-2):147-53 - PubMed
  16. Stat Methods Med Res. 2007 Aug;16(4):309-30 - PubMed
  17. J Med Genet. 2012 Aug;49(8):533-8 - PubMed
  18. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8681-5 - PubMed
  19. Clin Pharmacol Ther. 1983 Apr;33(4):529-36 - PubMed
  20. J Bone Miner Res. 2006 Sep;21(9):1433-42 - PubMed
  21. J Clin Endocrinol Metab. 2002 Dec;87(12):5760-8 - PubMed
  22. G3 (Bethesda). 2016 Sep 08;6(9):2909-18 - PubMed
  23. Curr Vasc Pharmacol. 2016;14(1):116-24 - PubMed
  24. J Endocrinol Invest. 2004;27(6 Suppl):120-7 - PubMed
  25. FASEB J. 1997 May;11(6):404-18 - PubMed
  26. J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72 - PubMed
  27. Diabetes Care. 2000 May;23(5):595-601 - PubMed
  28. J Clin Endocrinol Metab. 2015 Apr;100(4):E672-80 - PubMed
  29. Biochem J. 1978 May 15;172(2):247-51 - PubMed
  30. Biochem Pharmacol. 1982 Dec 15;31(24):3997-4000 - PubMed
  31. BMC Med Genet. 2010 May 02;11:68 - PubMed
  32. J Clin Endocrinol Metab. 2007 Jul;92(7):2659-64 - PubMed
  33. IUBMB Life. 2003 Jan;55(1):1-11 - PubMed
  34. Aging Male. 2006 Dec;9(4):195-9 - PubMed
  35. Dev Dyn. 2007 May;236(5):1313-8 - PubMed
  36. PLoS One. 2012;7(12):e51917 - PubMed
  37. Am Heart J. 2008 May;155(5):823-8 - PubMed
  38. Pflugers Arch. 2014 Jan;466(1):131-7 - PubMed
  39. Am J Med Genet C Semin Med Genet. 2003 Aug 15;121C(1):32-7 - PubMed
  40. Endocr Rev. 2003 Apr;24(2):152-82 - PubMed
  41. J Clin Pharmacol. 1999 Apr;39(4):327-48 - PubMed
  42. J Clin Endocrinol Metab. 2005 Jun;90(6):3600-5 - PubMed
  43. Physiology (Bethesda). 2012 Feb;27(1):7-14 - PubMed

Publication Types

Grant support